| Bioactivity | Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63[1]. |
| Name | Neurodegenerative Disorder-Targeting Compound 1 |
| CAS | 1254698-39-9 |
| Formula | C28H28N4O4 |
| Molar Mass | 484.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Helmut Mack, et al. Carboxamide compounds and their use as calpain inhibitors. WO2010128102A1. |
Neurodegenerative Disorder-Targeting Compound 1
CAS: 1254698-39-9 F: C28H28N4O4 W: 484.55
Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound ex
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.